It has been recently shown that increasing the level of Cx43 in human LN18 and LN229 glioma cells enhances resistance to TMZ, while knockdown of Cx43 sensitizes them to TMZ, demonstrating a fundamental role of gap junctions in the responsiveness to chemotherapics (Gielen et al., 2013). The gene discussed is GJA1; the disease is central nervous system cancer.